Reply  by Tomaschitz, Andreas et al.
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October 26, 2010:1514–6ensing mechanisms (i.e., renal perfusion), stronger correlations
etween ARR and central BP, compared with brachial BP, may
e expected. This was not observed in the Tomaschitz et al. (1)
tudy.
With each cardiac ejection, there is generation of forward
raveling pressure waves that move at high speed (e.g., 5 to 20 m/s)
rom proximal elastic large arteries (e.g., the aorta and carotid
rtery) distally through increasingly less compliant vasculature
e.g., the brachial and radial arteries). Some of these waves are
eflected back to the heart. Overall, the result is amplification of
he pressure pulse such that central SBP is always lower than
rachial SBP, whereas brachial diastolic blood pressure (DBP)
emains similar or is slightly lower (e.g., 1 to 3 mm Hg) than
entral DBP (5). In patient populations similar to that reported by
omaschitz et al. (1), directly recorded central SBP is expected to
e approximately 10 to 17 mm Hg lower than peripheral SBP
6,7), but this is not the case as presented by Tomaschitz et al. (1).
ndeed, in places throughout the text, brachial SBP is lower than
entral SBP and central DBP is up to 10 mm Hg lower than
rachial DBP.
What explains this nonphysiologic discordance between bra-
hial and central BP? Could this be a result of different method-
logies and time points at which brachial and central BPs were
cquired? For correct data interpretation, this requires clarification.
n any case, perhaps the relationship between ARR and central and
rachial BP may be best explored using noninvasive central BP
ethods combined with traditional upper arm BP. This approach
lso would enable scrutiny of the relationship between BP ampli-
cation and ARR and, importantly, would negate the confounding
ffects associated with measuring BP in the coronary catheteriza-
ion laboratory.
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e thank Dr. Sharman for his interest in our paper regarding the
ssociations of the aldosterone-to-renin ratio with arterial blood
ressure (BP) (1). We appreciate his insightful comments on the
ifferences between peripheral and central BP levels in the LURIC
Ludwigshafen Risk and Cardiovascular Health) study.
Dr. Sharman correctly stated that systolic BP, as the pulsatile
omponent of BP, is amplified with increasing distance from the
ortic root, resulting in higher peripheral than corresponding
entral BP levels. In fact, in LURIC we observed slightly lower
eripheral systolic BP levels (141  24 mm Hg) that were
easured on the morning of the day when coronary angiography
as scheduled (and that constituted the mean of 3 measurements),
han central aortic systolic BP values (143 30 mm Hg) that were
etermined invasively once during routine diagnostic cardiac cath-
terization later in the day. Peripheral diastolic BP measurements
81  11 mm Hg) were higher than aortic diastolic BP levels
71  12 mm Hg), and here the same limitations apply regarding
requency and timing of the 2 measurements.
The pressure amplification phenomenon generally is more
ronounced in the younger age group and diminishes with aging
ecause of the development of progressive aortic stiffening (2). The
URIC cohort represents an elderly population, presumably with
ncreased mean vascular stiffness, as can be deduced from the large
ercentage of participants exhibiting coronary artery disease (78%).
e therefore believe that in addition to the above considerations,
less pronounced pressure amplification might have accounted for
he differences seen in diastolic BP levels. Furthermore, ongoing
ntihypertensive drug treatment, which was noted for 86.8% of the
URIC participants, additionally might have influenced the rela-
ionship between central and peripheral BP values because periph-
ral BP measurements were obtained earlier in the day than
nvasive BP measurements (2).
We agree with Dr. Sharman that noninvasive measurements of
entral BP are an appropriate approach. However, it has been
ecommended in a consensus document pertaining to central BP
easurements that central BP ideally should be determined
nvasively (3). Although it has been shown that noninvasive, that
s, tonometric, methods also may measure central BP accurately,
naccurate measurement of cuff pressure, heart rate, height, age,
ngoing medication, and observer-dependent factors may consti-
ute important confounders of this method (3,4). We therefore
elieve that invasive central BP measurement during cardiac
atheterization was a reliable method for estimating aortic BP
alues, despite the fact that the scheduling of peripheral and aortic
P measurements at 2 different time points was suboptimal. We
evertheless found it important to report both central and periph-
ral BP datasets to demonstrate that there is a strong relationship
etween the aldosterone-to-renin ratio and BP, independent of the
ethod used for measurement of BP. The concordant finding with
oth methods strengthens our findings and underlines the impor-
ant role of inappropriate aldosterone levels in the pathogenesis of
rterial hypertension and cardiovascular disease (5,6).
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